15例真菌败血症的回顾性研究

被引:25
作者
邓国华
王爱霞
机构
[1] 中国医学科学院、中国协和医科大学北京协和医院感染内科,中国医学科学院、中国协和医科大学北京协和医院感染内科,
关键词
真菌血症; 抗真菌药; 预后;
D O I
暂无
中图分类号
R519 [真菌与放线菌传染病];
学科分类号
100401 ;
摘要
目的 探讨真菌败血症的治疗及早期诊断 ,以改善预后。方法 结合文献复习 ,回顾性研究 1992年 8月~ 2 0 0 0年 9月间的 15例真菌败血症患者的临床特征、治疗效果及预后。结果  15例中 ,除 1例为社区获得性感染外 ,14例为医院获得性感染 ;后者首次阳性血培养前的住院时间 7d~12个月 ,中位数为 1 5个月。易感危险因素中 ,以严重基础疾病 (10例 / 15例 )、使用广谱抗生素 (14例/ 15例 )、应用糖皮质激素或化疗药物 (11例 / 15例 )的因素最为突出 ,少数 (4例 / 15例 )有中性粒细胞减少。而具有上述两种以上易感危险因素者达 11例。主要致病菌为念珠菌属包括白色念珠菌和非白色念珠菌属 (如热带念珠菌、近平滑念珠菌等 )。病死率为 5 3 3% (8/ 15 )。对抗真菌治疗有效的 7例中 ,合并心内膜炎的 2例成功地施行了瓣膜赘生物 (直径均 >1cm)清除术。结论 本组败血症多发生在机体防御功能明显降低的患者中 ,主要致病菌为白色念珠菌和非白色念珠菌属 ,尽可能及早明确诊断和治疗有助于降低病死率。
引用
收藏
页码:21 / 23
页数:3
相关论文
共 9 条
[1]  
A double-blind, randomized,placebo-controlled trial of itraconazole capsules as antifungal prophylaxis for neutropenic patients. Nucci M,Biasoli I,Akiti T,et al. Clinical Infectious Diseases . 2000
[2]  
Nosocomial fungemia: a 2year prospective study. Costa SF,Marinho I,Araujo EA,et al. Journal of Hospital Infection . 2000
[3]  
Difinitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis.The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Bone RC,Balk RA,Gerra FB,et al. Chest . 1992
[4]  
Microwave-stimulated JonesMarres method for staining fungi in brain tissue of immunocompromised patients. Boon ME,Barlow Y,Marres EM,et al. Methods . 1998
[5]  
Combination therapy with amphotericin B and fluconazole against invasive candidiasis in neutropenic-mouse and infective-endocarditis rabbit models. Sanati H,Ramos CF,Bayer AS,et al. Antimicrobial Agents and Chemotherapy . 1997
[6]  
Efficacies of high-dose fluconazole plus amphotericin B and high-dose fluconazole plus 5-fluorocytosine versus amphotericin B, fluconazole, and 5-flurocytosine monotherapies in treatment of experimental endocarditis, endophthalmitis, and pyelonephritis du. Louie A,Liu W,Miller DA,et al. Antimicrobial Agents and Chemotherapy . 1999
[7]  
ArandomizedstudycomparingfluconazolewithamphotericinB/5 flucytosineforthetreatmentofsystemicCandidainfectionsinintensivecarepatients. AbeleHornM,KoppA,SternbergU,etal. Journal of Infection . 1996
[8]  
Analysis by pulsed-field gel electrophoresis of Candida albicans that developed resistance during antifungal therapy. Mori T,Matsumura M,Oguri T. Japanese Journal of Medical Mycology . 1998
[9]  
Trichosporon beigelii infection: experience in a regional burn center. Cawley MJ,Braxton GR,Haith LR,et al. Burns . 2000